Annual FCF
-$83.45 M
-$23.03 M-38.12%
31 December 2023
Summary:
Kezar Life Sciences annual free cash flow is currently -$83.45 million, with the most recent change of -$23.03 million (-38.12%) on 31 December 2023. During the last 3 years, it has fallen by -$46.31 million (-124.69%). KZR annual FCF is now -882.05% below its all-time high of -$8.50 million, reached on 31 December 2017.KZR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$17.51 M
-$481.00 K-2.82%
30 September 2024
Summary:
Kezar Life Sciences quarterly free cash flow is currently -$17.51 million, with the most recent change of -$481.00 thousand (-2.82%) on 30 September 2024. Over the past year, it has increased by +$2.83 million (+13.91%). KZR quarterly FCF is now -943.00% below its all-time high of -$1.68 million, reached on 31 December 2017.KZR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$76.39 M
+$2.83 M+3.57%
30 September 2024
Summary:
Kezar Life Sciences TTM free cash flow is currently -$76.39 million, with the most recent change of +$2.83 million (+3.57%) on 30 September 2024. Over the past year, it has increased by +$4.31 million (+5.35%). KZR TTM FCF is now -3696.52% below its all-time high of -$2.01 million, reached on 31 March 2017.KZR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KZR Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.1% | +13.9% | +5.3% |
| 3 y3 years | -124.7% | -75.5% | -87.2% |
| 5 y5 years | -280.9% | -110.5% | -164.8% |
KZR Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -124.7% | at low | -75.5% | +23.8% | -87.2% | +10.3% |
| 5 y | 5 years | -280.9% | at low | -142.3% | +23.8% | -164.8% | +10.3% |
| alltime | all time | -882.0% | at low | -943.0% | +23.8% | -3696.5% | +10.3% |
Kezar Life Sciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.51 M(+2.8%) | -$76.39 M(-3.6%) |
| June 2024 | - | -$17.03 M(-25.5%) | -$79.22 M(-7.0%) |
| Mar 2024 | - | -$22.86 M(+20.4%) | -$85.16 M(+2.0%) |
| Dec 2023 | -$83.45 M(+38.1%) | -$18.98 M(-6.7%) | -$83.45 M(+3.4%) |
| Sept 2023 | - | -$20.34 M(-11.5%) | -$80.70 M(+4.4%) |
| June 2023 | - | -$22.98 M(+8.6%) | -$77.32 M(+14.0%) |
| Mar 2023 | - | -$21.16 M(+30.4%) | -$67.82 M(+12.2%) |
| Dec 2022 | -$60.42 M(+41.3%) | -$16.23 M(-4.3%) | -$60.42 M(+8.8%) |
| Sept 2022 | - | -$16.96 M(+25.9%) | -$55.55 M(+14.4%) |
| June 2022 | - | -$13.47 M(-2.1%) | -$48.56 M(+0.8%) |
| Mar 2022 | - | -$13.76 M(+21.3%) | -$48.16 M(+12.6%) |
| Dec 2021 | -$42.75 M(+15.1%) | -$11.35 M(+13.7%) | -$42.75 M(+4.8%) |
| Sept 2021 | - | -$9.98 M(-23.6%) | -$40.80 M(+1.8%) |
| June 2021 | - | -$13.07 M(+56.4%) | -$40.07 M(+8.0%) |
| Mar 2021 | - | -$8.36 M(-11.0%) | -$37.11 M(-0.1%) |
| Dec 2020 | -$37.14 M | -$9.39 M(+1.5%) | -$37.14 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$9.25 M(-8.5%) | -$34.98 M(+2.7%) |
| June 2020 | - | -$10.11 M(+20.4%) | -$34.05 M(+5.9%) |
| Mar 2020 | - | -$8.39 M(+16.1%) | -$32.14 M(+5.4%) |
| Dec 2019 | -$30.48 M(+39.1%) | -$7.23 M(-13.1%) | -$30.48 M(+5.7%) |
| Sept 2019 | - | -$8.32 M(+1.5%) | -$28.85 M(+14.4%) |
| June 2019 | - | -$8.20 M(+21.8%) | -$25.22 M(+2.2%) |
| Mar 2019 | - | -$6.73 M(+20.5%) | -$24.68 M(+12.7%) |
| Dec 2018 | -$21.91 M(+157.8%) | -$5.59 M(+19.1%) | -$21.91 M(+21.7%) |
| Sept 2018 | - | -$4.69 M(-38.8%) | -$18.00 M(+13.8%) |
| June 2018 | - | -$7.67 M(+93.6%) | -$15.81 M(+51.4%) |
| Mar 2018 | - | -$3.96 M(+135.9%) | -$10.45 M(+22.9%) |
| Dec 2017 | -$8.50 M(-14.1%) | -$1.68 M(-32.9%) | -$8.50 M(+24.6%) |
| Sept 2017 | - | -$2.50 M(+8.7%) | -$6.82 M(+58.0%) |
| June 2017 | - | -$2.30 M(+14.5%) | -$4.32 M(+114.5%) |
| Mar 2017 | - | -$2.01 M | -$2.01 M |
| Dec 2016 | -$9.89 M | - | - |
FAQ
- What is Kezar Life Sciences annual free cash flow?
- What is the all time high annual FCF for Kezar Life Sciences?
- What is Kezar Life Sciences annual FCF year-on-year change?
- What is Kezar Life Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for Kezar Life Sciences?
- What is Kezar Life Sciences quarterly FCF year-on-year change?
- What is Kezar Life Sciences TTM free cash flow?
- What is the all time high TTM FCF for Kezar Life Sciences?
- What is Kezar Life Sciences TTM FCF year-on-year change?
What is Kezar Life Sciences annual free cash flow?
The current annual FCF of KZR is -$83.45 M
What is the all time high annual FCF for Kezar Life Sciences?
Kezar Life Sciences all-time high annual free cash flow is -$8.50 M
What is Kezar Life Sciences annual FCF year-on-year change?
Over the past year, KZR annual free cash flow has changed by -$23.03 M (-38.12%)
What is Kezar Life Sciences quarterly free cash flow?
The current quarterly FCF of KZR is -$17.51 M
What is the all time high quarterly FCF for Kezar Life Sciences?
Kezar Life Sciences all-time high quarterly free cash flow is -$1.68 M
What is Kezar Life Sciences quarterly FCF year-on-year change?
Over the past year, KZR quarterly free cash flow has changed by +$2.83 M (+13.91%)
What is Kezar Life Sciences TTM free cash flow?
The current TTM FCF of KZR is -$76.39 M
What is the all time high TTM FCF for Kezar Life Sciences?
Kezar Life Sciences all-time high TTM free cash flow is -$2.01 M
What is Kezar Life Sciences TTM FCF year-on-year change?
Over the past year, KZR TTM free cash flow has changed by +$4.31 M (+5.35%)